Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Echinacea, Propolis and Vitamin C for URI Prevention in Preschoolers

This study has been completed.
Sponsor:
Information provided by:
The Cleveland Clinic
ClinicalTrials.gov Identifier:
NCT00231218
First received: September 30, 2005
Last updated: December 13, 2006
Last verified: December 2006
  Purpose

We hypothesize the herbal preparation will enhance the preschoolers' immune response and when taken prophylactically for 12 weeks will decrease episodes of upper respiratory infections and gastroenteritis in the active versus the control group.


Condition Intervention Phase
Common Cold
Gastroenteritis
Drug: dietary supplement--echinacea, propolis, and vitamin c
Phase 3

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Parallel Assignment
Masking: Double-Blind
Primary Purpose: Prevention
Official Title: the Effectiveness of Echinacea, Propolis and Vitamin C in the Prevention of Respiratory Tract Infections and Gastroenteritis in Preschool Age Children: a Prospective Study

Resource links provided by NLM:


Further study details as provided by The Cleveland Clinic:

Primary Outcome Measures:
  • upper respiratory tract infections

Secondary Outcome Measures:
  • gastroenteritis

Estimated Enrollment: 104
Study Start Date: January 2006
Estimated Study Completion Date: March 2006
Detailed Description:

This combination of herbs has been studied only once before in preschoolers. In a study of 430 preschoolers reported in Archives of Pediatric and Adolescent Medicine in March of 2004, a similar preparation with a slightly lower dose of Vitamin C decreased upper respiratory infections by 55% (308 to 138). We are repeating this study to see if our results confirm or contradict those of the previous study.

  Eligibility

Ages Eligible for Study:   3 Years to 6 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Age 3-6

Exclusion Criteria:

  • Cystic fibrosis
  • Immunodeficiency
  • Bronchopulmonary dysplasia
  • Anatomic abnormalities of respiratory tract
  • Intestinal malabsorption
  • Allergy to sunflower seeds
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00231218

Locations
United States, Ohio
Cleveland Clinic Foundation
Cleveland, Ohio, United States, 44195
Sponsors and Collaborators
The Cleveland Clinic
Investigators
Study Director: michael l macknin, m.d. The Cleveland Clinic
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00231218     History of Changes
Other Study ID Numbers: 8348
Study First Received: September 30, 2005
Last Updated: December 13, 2006
Health Authority: United States: Institutional Review Board

Keywords provided by The Cleveland Clinic:
vitamin c
echinacea
propolis
upper respiratory tract infection
common cold
gastroenteritis
dietary supplement
herbal remedy

Additional relevant MeSH terms:
Common Cold
Gastroenteritis
Respiratory Tract Infections
Digestive System Diseases
Gastrointestinal Diseases
Infection
Picornaviridae Infections
RNA Virus Infections
Respiratory Tract Diseases
Virus Diseases
Ascorbic Acid
Propolis
Vitamins
Anti-Infective Agents
Antioxidants
Growth Substances
Micronutrients
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Physiological Effects of Drugs
Protective Agents
Therapeutic Uses

ClinicalTrials.gov processed this record on November 27, 2014